"improving the quality and representativeness of the treatment center program data"

Ended Awarded Last action

Contract number
75F40119F19007
Awardee
Awarding agency
Obligated
$816,802

Award facts

Contract value 100% obligated
$816,801.67 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Herndon, VA 20170, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 -$325,480
Other Administrative Action P00004 $325,436
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $816,846

About this award

The Food and Drug Administration (FDA) awarded a delivery order valued at $816,801.67 to Denver Health and Hospital Authority (doing business as Denver Health) on September 20, 2019, for work related to improving the quality and representativeness of Treatment Center Program data used in post-marketing surveillance of prescription and over-the-counter drug abuse. The contract, which operates under firm fixed-price terms with an ultimate completion date of March 5, 2026, represents work to be performed at Denver Health's location in Herndon, Virginia. This delivery order is issued under the FDA's larger $10 million multiple-award Indefinite Delivery Contract (IDC) titled "FDA Prescription Drug Abuse Summary Reports," which serves as an umbrella vehicle for ongoing pharmaceutical surveillance and drug use trend monitoring activities. No set-aside designation was applied to this award, reflecting Denver Health's status as the sole responsible or most qualified source for this specialized federal health surveillance work.

Denver Health, a 555-bed academic healthcare system and the City and County of Denver's only Level I trauma center, brings substantial expertise in federal health data initiatives and pharmaceutical surveillance to this engagement. The organization has previously executed multiple delivery orders under the FDA's data resources IDC, conducting surveys on nonmedical use of prescription drugs, falsified and unapproved pharmaceuticals, and hallucinogenic drug trends, with prior contract values ranging from $205,010 to $309,340. Beyond its FDA work, Denver Health maintains an extensive federal portfolio including a $3,015,216.50 Centers for Disease Control and Prevention (CDC) delivery order for vaccine safety monitoring under a $149 million IDC, demonstrating its established capabilities in federal health surveillance, data collection, and analytics across multiple public health domains.

Quick answers

Who was awarded contract 75F40119F19007?

75F40119F19007 was awarded to Denver Health And Hospital Authority by Food and Drug Administration (Department of Health and Human Services) on September 20, 2019.

How much is contract 75F40119F19007 worth?

The government has obligated $816,802 on 75F40119F19007.

Is contract 75F40119F19007 an order under another contract?

Yes. 75F40119F19007 is a delivery order under HHSF223201610028I, an indefinite delivery contract, on FDA Prescription Drug Abuse Summary Reports.

Was contract 75F40119F19007 competed?

The extent of competition for 75F40119F19007 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award